$55+ Billion Stroke Management Market Size to Rise at a Stellar CAGR of 7.5% During (2022-2028) - COVID-19 Impact and Global Analysis by The Insight Partners
18 oct. 2022 08h40 HE
|
The Insight Partners
New York, Oct. 18, 2022 (GLOBE NEWSWIRE) -- According to The Insight Partners latest market study on "Stroke Management Market Size, Share, Trends, Growth Strategy and Forecast to 2028 – COVID-19...
GNT Pharma Provides Update on Two Phase III Studies of Nelonemdaz for Acute Ischemic Stroke Patients Treated with tPA (ENIS-3) or Endovascular Thrombectomy (RODIN)
19 sept. 2022 09h00 HE
|
GNT Pharma Co., Ltd
Promising efficacy and safety profiles were observed in prior Phase II studies in acute ischemic stroke patients treated with recanalization therapies. The ENIS-3 trial has achieved >33% of...
Algernon Pharmaceuticals Receives Approval for Groundbreaking Phase 1 DMT Human Stroke Study
12 sept. 2022 07h00 HE
|
Algernon Pharmaceuticals
VANCOUVER, British Columbia, Sept. 12, 2022 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) a clinical stage...
Non-Emergency Medical Transportation Market Size Worth $15.57Bn, Globally, by 2028 to Growing at 9.0% CAGR | Exclusive Report by The Insight Partners
24 août 2022 05h37 HE
|
The Insight Partners
New York, Aug. 24, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on "Non-Emergency Medical Transportation Market Forecast to 2028 – COVID-19 Impact and Global...
Stroke Across America: Only 500 Miles Remain in 4,300-Cycling Journey to Raise Awareness for Stroke & Aphasia
18 août 2022 13h15 HE
|
Stroke Across America
PORTOLA VALLEY, Calif., Aug. 18, 2022 (GLOBE NEWSWIRE) -- What do two educators, a nonprofit executive, and a former varsity soccer college athlete have in common? Brain Injury. They join the more...
Rapid Implementation of Electrotherapy in Musculoskeletal Disorder Treatment Enhancing Efficacy of Neurorehabilitation Devices: Fact.MR
09 août 2022 22h00 HE
|
FACT.MR
Seoul, South Korea, Aug. 10, 2022 (GLOBE NEWSWIRE) -- As per the latest industry analysis by Fact.MR, a market research and competitive intelligence provider, sales of neurorehabilitation devices...
Recovering From Stroke, Ex-Stanford Professor is Halfway Across America, Riding to Raise Awareness for Stroke and Aphasia
25 juil. 2022 22h31 HE
|
Stroke Onward
PORTOLA VALLEY, Calif., July 25, 2022 (GLOBE NEWSWIRE) -- For the past eight weeks, a team of cyclists has been pedaling its way across America, spreading awareness about stroke and the emotional...
Telestroke Services Market Size Worth $4.67223 Million by 2028 to Rise at a Stellar CAGR of 20.2% by 2028 | Exclusive Report By The Insight Partners
12 juil. 2022 10h07 HE
|
The Insight Partners
New York, July 12, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Telestroke Services Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type, End...
Algernon Pharmaceuticals Provides Update on Its Phase 1 DMT Stroke Study
07 juil. 2022 07h00 HE
|
Algernon Pharmaceuticals
VANCOUVER, British Columbia, July 07, 2022 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a clinical stage Canadian...
PathMaker Neurosystems Receives $100,000 START Award from MassVentures
08 juin 2022 07h00 HE
|
PathMaker Neurosystems Inc.
BOSTON, June 08, 2022 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. (“PathMaker”), a near-commercial stage neuromodulation company developing breakthrough non-invasive systems for the treatment of...